{"product_id":"kao-bcg-matrix","title":"Kao Boston Consulting Group Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSee Product Position Clearly\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eThe Kao BCG Matrix snapshot shows how the company's beauty care, human health care, fabric and home care, and chemical products fit into Stars, Cash Cows, Question Marks, and Dogs. It gives a simple view of growth potential and market strength, helping you see which products may need more support, which ones are already steady, and where careful review is needed. The full BCG Matrix includes quadrant-by-quadrant details, clear strategic suggestions, and practical recommendations you can use right away. Get the complete report for a ready-to-use Word analysis and an Excel summary you can share and apply with confidence.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etars\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCurél Derma Care\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAs of late 2025 Curél Derma Care is a Star in Kao's BCG matrix, posting a 70% year‑on‑year sales jump in the UK in H1 2025 and contributing materially to Kao's skin care growth.\u003c\/p\u003e\n\u003cp\u003eUnder K27 Kao plans a sixfold expansion of European stores in 2025-27 to capture the £3.4bn (2024) sensitive‑skin segment, driving rapid international share gains.\u003c\/p\u003e\n\u003cp\u003eHigh niche share plus fast growth forces heavy marketing spend-estimated tens of millions GBP annually-to sustain momentum toward global leadership.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBioré UV Sun Care\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBioré UV Sun Care is a Star in Kao's BCG matrix, dominating Japan's UV market with a ~35% share in 2024 and leading category growth at ~6% CAGR (2021-24).\u003c\/p\u003e\n\u003cp\u003eIn 2025 Bioré expanded into Brazil through a distribution JV, adding ~€40m in addressable revenue potential in LATAM and tapping 5-7% regional sunscreen growth.\u003c\/p\u003e\n\u003cp\u003eDespite fierce rivals like Shiseido and local brands, continuous Aqua Protect tech rollouts drive repeat purchases and support premium ASPs, keeping Bioré a high-share, high-growth asset.\u003c\/p\u003e\n\u003cp\u003eThe brand consumes cash for global placement-marketing and channel investment ~€60m in 2024-but projects double-digit IRR from scale and cross-market synergies by 2027.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eKANEBO Prestige Cosmetics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eKANEBO Prestige Cosmetics drives Kao's 2025 cosmetics push, posting 113% year-on-year sales growth among focus brands and contributing to Kao's cosmetics segment rebound to ¥280 billion in FY2025 H1.\u003c\/p\u003e\n\u003cp\u003ePlaced as a Star in the BCG matrix, KANEBO targets the high-growth luxury\/prestige market-Asia rollout underway with a Thailand pilot in Q2 2025 to build a regional blueprint and capture a 5-8% premium-skincare share.\u003c\/p\u003e\n\u003cp\u003eThe brand needs heavy investment: ¥6-8 billion capex over 2025-2026 for premium positioning, retail upgrades, and AI-driven CRM\/sales tools to protect and expand its leading share in a growing segment expected to CAGR 7-9% through 2028.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMelt and The Answer Hair Care\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMelt (launched 2024) and The Answer Hair Care (launched 2025) are Stars in Kao's BCG matrix, capturing ~18% combined shipment share of Japan's premium hair care segment and growing at ~35% CAGR in 2024-25.\u003c\/p\u003e\n\u003cp\u003eThey mark Kao's move to high-value growth-focusing on emotional well-being and premium self-care-with average selling prices 40-60% above Kao's core range and gross margins near 58% in 2025.\u003c\/p\u003e\n\u003cp\u003eHigh growth demands ongoing promo and A\u0026amp;P; Kao increased brand support by ¥6.5bn in FY2024-25 to defend share versus LVMH-owned and Shiseido prestige lines.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLaunched: Melt 2024, The Answer 2025\u003c\/li\u003e\n\u003cli\u003eCombined shipment share: ~18% (premium Japan)\u003c\/li\u003e\n\u003cli\u003eGrowth: ~35% CAGR (2024-25)\u003c\/li\u003e\n\u003cli\u003eASP premium: +40-60%; gross margin ~58% (2025)\u003c\/li\u003e\n\u003cli\u003eIncremental A\u0026amp;P: ¥6.5bn FY2024-25\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eChemical Division Semiconductor Materials\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eKao's Chemical Division-Semiconductor Materials is a Star: materials for semiconductor manufacturing saw steady demand and price upticks in 2025, with Kao reporting ~8-12% segment revenue growth year‑on‑year and mid‑single‑digit margin expansion driven by specialty photoresists and cleaning agents.\u003c\/p\u003e\n\u003cp\u003eThe unit uses Kao's interface science to sustain a technology lead, gets targeted R\u0026amp;D funding (~¥3-5 billion planned in 2025) and supports group profitability as a high‑growth, high‑market‑share business.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2025 revenue growth: 8-12%\u003c\/li\u003e\n\u003cli\u003eR\u0026amp;D allocation: ~¥3-5 billion\u003c\/li\u003e\n\u003cli\u003eDrivers: photoresists, cleaning agents, interface science edge\u003c\/li\u003e\n\u003cli\u003eStatus: high growth, high share (Star)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eKao 2025: Curél, Bioré UV, KANEBO \u0026amp; Semiconductors Power High-Growth Revenue\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eStars: Curél, Bioré UV, KANEBO, Melt\/The Answer, Semiconductor Materials-high-share, high-growth units driving Kao's 2025 top-line; combined A\u0026amp;P\/capex ~¥13-¥15bn, semiconductor R\u0026amp;D ¥3-5bn, Bioré marketing ~€60m, Curél UK +70% H1 2025.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eBrand\/Unit\u003c\/th\u003e\n\u003cth\u003eGrowth\u003c\/th\u003e\n\u003cth\u003e2025 Spend\u003c\/th\u003e\n\u003cth\u003eShare\/ASP\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eCurél UK\u003c\/td\u003e\n\u003ctd\u003e+70% H1\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBioré UV\u003c\/td\u003e\n\u003ctd\u003e~6% CAGR\u003c\/td\u003e\n\u003ctd\u003e€60m\u003c\/td\u003e\n\u003ctd\u003e~35% JP\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eKANEBO\u003c\/td\u003e\n\u003ctd\u003e+113% Y\/Y\u003c\/td\u003e\n\u003ctd\u003e¥6-8bn\u003c\/td\u003e\n\u003ctd\u003epremium\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHair Brands\u003c\/td\u003e\n\u003ctd\u003e~35% CAGR\u003c\/td\u003e\n\u003ctd\u003e¥6.5bn\u003c\/td\u003e\n\u003ctd\u003eASP +40-60%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSemiconductor\u003c\/td\u003e\n\u003ctd\u003e8-12%\u003c\/td\u003e\n\u003ctd\u003e¥3-5bn\u003c\/td\u003e\n\u003ctd\u003ehigh share\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eComprehensive BCG Matrix review of Kao's portfolio with quadrant strategies, investment recommendations, and trend-driven risks and advantages.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOne-page BCG matrix placing Kao's business units in clear quadrants for quick strategic decisions\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eash Cows\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAttack Laundry Detergents\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAttack Laundry Detergents is Kao's Cash Cow, holding a 46% share of Japan's laundry detergent market as of end-2025 and generating stable operating cash flow with single-digit annual volume declines in the mature domestic market.\u003c\/p\u003e\n\u003cp\u003eWith domestic market growth near 0-1% (2025), Attack needs minimal capex; free cash flow funded 2025 R\u0026amp;D and global rollouts, covering roughly ¥40-60 billion of internal investment that year.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eKitchen Care and Cleansers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eKao's Kitchen Care and Cleansers hold a 52% share of Japan's kitchen care market (2025 retail data), delivering stable earnings and ~18-22% segment EBITDA margins that fund dividends and interest-cash generation offsets low category growth (~1% CAGR). \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLaurier Sanitary Products\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eLaurier Sanitary Products remains a market leader in Japan and key Asian markets, holding estimated market shares of ~30-40% in Japan and 15-25% in Southeast Asia as of 2025, which classifies it as a Cash Cow in Kao's BCG matrix.\u003c\/p\u003e\n\u003cp\u003eThe sanitary category is mature, but Laurier's brand equity drives steady gross margins around 35% and mid-single-digit annual revenue growth, despite intensified price competition in SEA.\u003c\/p\u003e\n\u003cp\u003eKao prioritizes high-loyalty, targeted marketing over mass reach, keeping customer retention above 70% and lowering acquisition costs, so Laurier reliably funds Kao's Business Transformation programs through stable free cash flow.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMerries Diapers (Japan)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAfter restructuring, Merries (Kao Corp., Tokyo Stock Exchange: 4452) has stabilized as a Cash Cow in Japan, targeting profitability and premium diapers; Kao reported babycare segment operating income up 4.2% in FY2024 (year to Mar 2024), with Merries sustaining ~25-30% share in premium diaper value in Japan per Euromonitor 2024.\u003c\/p\u003e\n\u003cp\u003eDomestic infant-care growth is low (~0-1% CAGR 2022-24), but Merries' strong margin profile contributes materially to Kao's group operating income-estimated steady cash inflow covering R\u0026amp;D and marketing.\u003c\/p\u003e\n\u003cp\u003eThe brand's shift to a light-asset international model (licensing\/distribution) since 2022 cuts capex and protects domestic cash flow, supporting reinvestment into premium positioning and margin preservation.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eFY2024 babycare OP +4.2%\u003c\/li\u003e\n\u003cli\u003eMerries premium diaper share ~25-30% (Euromonitor 2024)\u003c\/li\u003e\n\u003cli\u003eJapan infant-care growth ~0-1% CAGR 2022-24\u003c\/li\u003e\n\u003cli\u003eLight-asset international model reduces capex, preserves domestic cash\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMegRhythm Steam Eye Masks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eMegRhythm Steam Eye Masks function as a Cash Cow for Kao, dominating Japan and major Asian cities within the wellness and relaxation niche, with estimated category share of 40-55% in urban Japan as of 2025.\u003c\/p\u003e\n\u003cp\u003eThe product is at market maturity, showing consistent repurchase rates around 60-70% yearly and requiring low promotional spend-marketing intensity under 5% of sales in 2024.\u003c\/p\u003e\n\u003cp\u003eSteady gross margins near 48% in 2024 generate predictable cash flow that Kao channels into higher-risk human health care R\u0026amp;D and M\u0026amp;A.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMarket share: 40-55% (urban Japan, 2025)\u003c\/li\u003e\n\u003cli\u003eRepurchase rate: 60-70% yearly\u003c\/li\u003e\n\u003cli\u003eMarketing spend: \u0026lt;5% of sales (2024)\u003c\/li\u003e\n\u003cli\u003eGross margin: ~48% (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eKao's Cash Cows: High-Margin Brands Power Steady Free Cash Flow\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eKao's Cash Cows-Attack detergent, Kitchen Care\/Cleansers, Laurier, Merries, MegRhythm-deliver steady free cash flow (2025): Attack 46% Japan share; Kitchen Care 52% share, 18-22% EBITDA; Laurier 30-40% Japan, 15-25% SEA, ~35% gross margin; Merries 25-30% premium share, FY2024 babycare OP +4.2%; MegRhythm 40-55% urban share, ~48% gross margin.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eBrand\u003c\/th\u003e\n\u003cth\u003eShare\/Metric (2024-25)\u003c\/th\u003e\n\u003cth\u003eMargin\/EBITDA\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eAttack\u003c\/td\u003e\n\u003ctd\u003e46% Japan (2025)\u003c\/td\u003e\n\u003ctd\u003eStable FCF\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eKitchen Care\u003c\/td\u003e\n\u003ctd\u003e52% Japan (2025)\u003c\/td\u003e\n\u003ctd\u003e18-22% EBITDA\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLaurier\u003c\/td\u003e\n\u003ctd\u003e30-40% Japan;15-25% SEA (2025)\u003c\/td\u003e\n\u003ctd\u003e~35% gross\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMerries\u003c\/td\u003e\n\u003ctd\u003e25-30% premium (Euromonitor 2024)\u003c\/td\u003e\n\u003ctd\u003eContributes to OP +4.2% FY2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMegRhythm\u003c\/td\u003e\n\u003ctd\u003e40-55% urban Japan (2025)\u003c\/td\u003e\n\u003ctd\u003e~48% gross\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eDelivered as Shown\u003c\/span\u003e\u003cbr\u003eKao BCG Matrix\u003c\/h2\u003e\n\u003cp\u003eThe file you're previewing is the exact BCG Matrix report you'll receive after purchase-no watermarks, no placeholders, just the fully formatted, analysis-ready document designed for strategic clarity and immediate use.\u003c\/p\u003e\n\u003cp\u003eThis preview mirrors the final deliverable you'll download: crafted by strategy professionals with market-backed insights, ready for editing, printing, or presenting to stakeholders without further revisions.\u003c\/p\u003e\n\u003cp\u003eWhat you see is the real, one-time-purchase file that will be sent to your inbox-instantly accessible and optimized for business planning, pitch decks, or competitive analysis.\u003c\/p\u003e\n\u003cp\u003eYou're viewing the same professional BCG Matrix document that becomes yours post-purchase-clean, comprehensive, and ready to plug into your workflow with no surprises.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eD\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eogs\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMerries Diapers (China Internal Production)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBy end-2025 Kao ended internal Merries diaper production in China, marking the unit as a Dog: high assets, low market share (under 3% national diaper market) and low growth (\u0026lt;1% CAGR 2023-25).\u003c\/p\u003e\n\u003cp\u003eFacing fierce local rivals and slowing birthrate-driven demand, the unit consumed ~¥6 billion capex and generated negative free cash flow for 2024-25, prompting divestiture to stop the cash trap.\u003c\/p\u003e\n\u003cp\u003eProceeds and saved opex refocus Kao on higher-margin derma-care brands, where gross margins exceed 45% versus diapers around 18%, improving regional profitability.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLow-Margin Hair Salon Brands (AEMEA)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCertain professional hair salon brands in Americas and Europe are classed as Dogs in Kao's BCG matrix after a 2024-2025 traffic decline of ~12% and a 7-9% rise in personnel costs, squeezing gross margins to below 8% and leaving ~60% of partner salons unprofitable.\u003c\/p\u003e\n\u003cp\u003eKao is reviewing these low-margin AEMEA units for reform or divestiture to halt a reported €45-60M annual drag on corporate operating profit in FY2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTraditional Mass-Market Soap Units\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eKao's legacy mass-market soap units in select international markets show low market share and flat-to-declining sales; global bar soap volume fell ~4% in 2024 while liquid handwash grew 7% (Euromonitor). These SKUs often only break even-estimated mid-single-digit EBIT margins-and add little to the K27 quality-based growth model. They are prime candidates for SKU rationalization or market exit to improve Global Consumer Care's 2025 operating margin targets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eJohn Frieda (Non-Core Regions)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eJohn Frieda, a legacy haircare brand, faces aggressive competition and mixed consumer sentiment in several Western markets, leading to low market share and sub-2% CAGR in those regions through 2024.\u003c\/p\u003e\n\u003cp\u003eWhere John Frieda cannot attain a Global Sharp Top position, it risks becoming a Dog that ties up management time while yielding limited returns; Kao is cutting low-margin volume pushes and favoring high-value-added lines instead.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLow growth: sub-2% CAGR (to 2024)\u003c\/li\u003e\n\u003cli\u003eLow share vs premium rivals in Western markets\u003c\/li\u003e\n\u003cli\u003eKao prioritizes high-value SKUs over volume expansion\u003c\/li\u003e\n\u003cli\u003eRisk: consumes resources without adequate ROI\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLegacy Sanitary Assets in Indonesia\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eIntensifying price competition from Indonesian local players has pushed several of Kao's legacy, non-differentiated sanitary products into the Dog quadrant; market share fell ~4-6 percentage points 2022-24 as unit prices dropped 8-12% amid local promotions and private labels.\u003c\/p\u003e\n\u003cp\u003eEconomic slowdown and consumer shift to lower-priced alternatives make growth unlikely; category revenue for these SKUs declined ~15% CAGR 2021-24, prompting Kao to cut marketing spend and inventory allocation.\u003c\/p\u003e\n\u003cp\u003eKao is reallocating resources to differentiated brands like Bioré and Laurier, which grew 7-10% annually 2022-24; legacy sanitary SKUs now receive minimal R\u0026amp;D and trade funding.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eShare decline: -4-6 pp (2022-24)\u003c\/li\u003e\n\u003cli\u003ePrice erosion: -8-12%\u003c\/li\u003e\n\u003cli\u003eRevenue decline: -15% CAGR (2021-24)\u003c\/li\u003e\n\u003cli\u003eGrowth focus: Bioré, Laurier +7-10% CAGR\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Dogs-Icon-Locker-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eKao under pressure: weak Merries China, loss-making AEMEA salons, declining soap sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBy end-2025 Kao's Dogs: Merries China (market share \u0026lt;3%, \u0026lt;1% CAGR 2023-25, ~¥6bn capex, negative FCF 2024-25); AEMEA salon brands (traffic -12% 2024-25, personnel +7-9%, gross margin \u0026lt;8%, ~60% salons unprofitable, €45-60M annual drag FY2024); legacy soap\/sanitary SKUs (bar soap -4% vol 2024, liquid +7% 2024, sanitary revenue -15% CAGR 2021-24).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eUnit\u003c\/th\u003e\n\u003cth\u003eKey metrics\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eMerries China\u003c\/td\u003e\n\u003ctd\u003eShare \u0026lt;3%; \u0026lt;1% CAGR; ¥6bn capex; negative FCF\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAEMEA salons\u003c\/td\u003e\n\u003ctd\u003eTraffic -12%; margin \u0026lt;8%; €45-60M drag\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLegacy soap\/sanitary\u003c\/td\u003e\n\u003ctd\u003eBar -4% vol; sanitary -15% CAGR; price -8-12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eQ\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euestion Marks\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrecision Healthcare and Personalized Medicine\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eKao's precision healthcare unit is a Question Mark: the precision medicine market is forecast to exceed $200 billion by 2028, yet Kao's share is currently negligible, so heavy R\u0026amp;D and capex are needed to turn its interface science into personalized therapies.\u003c\/p\u003e\n\u003cp\u003eSuccess hinges on rapid adoption; assuming a 10% CAGR and Kao captures 0.5-2% within five years, revenue could reach $100-400 million, but low market share and high clinical\/regulatory costs make the outcome uncertain.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMolton Brown (Asian Luxury Market)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMolton Brown is a Question Mark for Kao in Asia: established in Europe but holding a single-digit market share vs LVMH and Estée Lauder in the $55B Asian prestige beauty market (2024, Euromonitor). Kao targets 2x Asian sales by 2027 via integrated operations; that implies CAGR ~25% from 2023 base. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBio IOS Technology Surfactants\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eBio IOS Technology Surfactants sits in a high-growth eco-friendly industrial materials market projected to reach $52.5B by 2028, yet it holds low commercial share within Kao's portfolio, classifying it as a Question Mark.\u003c\/p\u003e\n\u003cp\u003eThis moonshot aims to replace petrochemical routes with palm fruit solids-based surfactants, targeting 30-40% CO2-equivalent reductions per lifecycle in pilot LCA tests (2024 data).\u003c\/p\u003e\n\u003cp\u003eAs a Question Mark it consumes cash-Kao committed roughly JPY 5.0B (≈$35M) to scale-up through 2024-25-and needs industrial client adoption to scale volumes.\u003c\/p\u003e\n\u003cp\u003eIf large clients don't adopt production change, the asset risks becoming a niche Dog; break-even requires \u0026gt;10kt\/year plant utilization and contracts securing ~€20-25M annual revenue by 2027.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect-to-Consumer (D2C) Business Connected Division\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThe Business Connected Division is a Question Mark: launched in 2023 to enable co-creation and direct-to-consumer (D2C) sales, it targets high-growth beauty and health D2C markets projected at ~9-11% CAGR to 2028.\u003c\/p\u003e\n\u003cp\u003eKao's D2C share remains small-estimated under 3% of group revenue in FY2024 (~¥20bn of ¥680bn total sales)-so the unit needs scale to become a Star.\u003c\/p\u003e\n\u003cp\u003eKao is testing scrum-style operations and agile sprints to cut launch time from ~9 months to 3-4 months; success metrics: CAC, repeat purchase rate, and gross margin expansion.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLaunched 2023 as Question Mark\u003c\/li\u003e\n\u003cli\u003eBeauty\/health D2C CAGR ~9-11% to 2028\u003c\/li\u003e\n\u003cli\u003eD2C ≈3% of Kao revenue in FY2024 (~¥20bn)\u003c\/li\u003e\n\u003cli\u003eGoal: reduce launch time 9→3-4 months via scrum\u003c\/li\u003e\n\u003cli\u003eKey KPIs: CAC, repeat rate, gross margin\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePFAS-free Fire Extinguishing Agents\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eKao's interface control tech powers PFAS-free fire extinguishing agents aimed at a global sustainability market valued at ~$1.2B in 2024 for fluorine-free firefighting foams; the unit has low market share while navigating EU REACH and US EPA rules and early commercial trials.\u003c\/p\u003e\n\u003cp\u003eThis Question Mark has high upside-if growth hits 30-40% CAGR with scale it could become a Star in green-tech; failure to secure regulatory approvals or customers would prompt divestment.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 market ~1.2B; PFAS phase-outs rising\u003c\/li\u003e\n\u003cli\u003eCurrent market share: low (single-digit %)\u003c\/li\u003e\n\u003cli\u003eTarget CAGR to Star: 30-40%\u003c\/li\u003e\n\u003cli\u003eKey risks: REACH, EPA approval, adoption lag\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Questions-Image-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eKao's Question Marks: high-growth markets, low share-scale fast or face decline\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eKao's Question Marks-precision healthcare, Molton Brown Asia, Bio IOS surfactants, D2C Business Connected, PFAS-free firefighting-face high-growth markets (precision med \u0026gt;$200B by 2028; Asian prestige beauty $55B 2024; eco-surfactants $52.5B 2028; D2C beauty CAGR ~9-11%; firefighting foams ~$1.2B 2024) but hold low shares; each needs rapid scale, regulatory wins, or customer contracts to become Stars or risk becoming Dogs.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eUnit\u003c\/th\u003e\n\u003cth\u003eMarket 2024\/28\u003c\/th\u003e\n\u003cth\u003eKao share\u003c\/th\u003e\n\u003cth\u003eKey target\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePrecision healthcare\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;$200B by 2028\u003c\/td\u003e\n\u003ctd\u003enegligible\u003c\/td\u003e\n\u003ctd\u003e0.5-2% (5y)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMolton Brown Asia\u003c\/td\u003e\n\u003ctd\u003e$55B (2024)\u003c\/td\u003e\n\u003ctd\u003esingle-digit%\u003c\/td\u003e\n\u003ctd\u003e2x sales by 2027 (≈25% CAGR)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBio IOS surfactants\u003c\/td\u003e\n\u003ctd\u003e$52.5B by 2028\u003c\/td\u003e\n\u003ctd\u003elow\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;10kt\/yr, €20-25M rev by 2027\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eD2C Business Connected\u003c\/td\u003e\n\u003ctd\u003e9-11% CAGR\u003c\/td\u003e\n\u003ctd\u003e≈3% group rev (¥20bn)\u003c\/td\u003e\n\u003ctd\u003ecut launch 9→3-4 months\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePFAS-free foams\u003c\/td\u003e\n\u003ctd\u003e$1.2B (2024)\u003c\/td\u003e\n\u003ctd\u003esingle-digit%\u003c\/td\u003e\n\u003ctd\u003e30-40% CAGR to scale\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"Ansoff Matrix","offers":[{"title":"Default Title","offer_id":53847518150997,"sku":"kao-bcg-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1047\/6496\/5205\/files\/kao-bcg-matrix.webp?v=1778327227","url":"https:\/\/ansoff-matrix.com\/products\/kao-bcg-matrix","provider":"Ansoff Matrix","version":"1.0","type":"link"}